Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and ...
Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its obesity-related ...
In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...
Hims & Hers Health (NYSE: HIMS) reported another blowout quarter recently, but the stock didn't get the type of pop that ...
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and ...
Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...
Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should ...
Digital health companies faced high advertising costs and focused on returns on investments in the third quarter.
Last week, Hims & Hers Health (NYSE:HIMS) dropped another mic with its latest earnings, and the numbers are mind-blowing.
Hims & Hers Health, Inc.’s HIMS investors are reaping some gains from the stock of late. Shares of the San Francisco, ...